Table 1 The present case and 17 reported surgical cases of recurrent IPNB [10, 12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27]
Primary lesion | Recurrence lesion | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
References | Year | Primary surgery | Resection margin | Pathological type | Second treatment | Pathological type | Location of Primary lesion | Location of Recurrence lesion | Recurrence below the primary tumor | Mucin production (Primary/Recurrence) | Conversion from non-invasive type to invasive type | Recurrence after the second surgery (months) |
[13] | 1996 | Lt. hepatectomy | Not listed | Not listed | Not listed | Not listed | IHBD | CBD | Yes | Not listed | Not listed | Not lised |
[14] | 2005 | Lt. hepatectomy | Not listed | Not listed | Anterior segmentectomy/ extrahepatic bile duct resection | Not listed | LHD | CBD | Yes | Yes/Yes | Not listed | Not lited |
[15] | 2006 | Extrahepatic bile duct resection | Negative | Not listed | PD | Not listed | Upper CBD | Lower CBD | Yes | Not listed | Yes | 12 |
[16] | 2007 | Cholecystectomy | Negative | Not listed | PD | Not listed | Cystic duct | Lower CBD | Yes | Yes/Yes | No | No recurrence |
[17] | 2008 | PD | Not listed | Not listed | Rt. hepatectomy | Not listed | Lower CBD | RHD | No | Not listed | Not listed | 24 |
[18] | 2009 | Lt. hepatectomy/cadate lobectomy | Negative | Not listed | Tumor enucleation | Not listed | B4 | CBD | Yes | Yes/Yes | No | 28 |
[19] | 2010 | Lt. hepatectomy/caudate lobectomy/gall bladder resection | Not listed | Not listed | PD | Not listed | LHD | CBD | Yes | Not listed | Not listed | No recurrence |
[20] | 2013 | Lt. hepatectomy/caudate lobectomy/extrahepatic bile duct resection | Negative | Not listed | PD | Not listed | LHD | CBD | Yes | Not listed | No | No recurrence |
[21] | 2013 | Cholecystectomy | Not listed | Gastric | Resected(details unknown) | Gastric | Gall bladder | Lower CBD | Yes | Not listed | No | Not listed |
[22] | 2014 | Lt. hepatectomy | Negative | Not listed | extrahepatic bile duct resection | Not listed | B2 | CBD | Yes | Yes/Yes | Yes | 35 |
[23] | 2015 | Rt. hepatectomy/caudate lobectomy/extrahepatic bile duct resection | Negative | Intestinal | PD | Intestinal | RHD | CBD | Yes | Yes/Yes | No | No recurrence |
[10] | 2015 | Lt. hepatectomy/caudate lobectomy/extrahepatic bile duct resection | Negative | Pancreaticobiliary | stent detention | Pancreaticobiliary | LHD | RHD | No | Not listed | Not listed | – |
[12] | 2016 | Rt. Hepatectomy | Positive | Intestinal | PD | Intestinal | RHD | CBD | Yes | Yes/Yes | No | No recurrence |
[24] | 2018 | Lt. hepatectomy/caudate lobectomy/extrahepatic bile duct resection | Negative | Not listed | stent detention | Not listed | LHD-CBD | B5 | No | Not listed | Not listed | – |
[25] | 2019 | Lt. hepatectomy | No listed | Not listed | Not listed | Not listed | LHD | RHD | No | Not listed | Not listed | Not listed |
[26] | 2019 | Extrahepatic bile duct resection | Negative | Not listed | Not listed | Not listed | CBD | Lower CBD | Yes | Not listed | Not listed | Not listed |
[27] | 2020 | Rt. hepatectomy/caudate lobectomy/extrahepatic bile duct resection | Negative | Pancreaticobiliary | PD | Pancreaticobiliary | RHD | CBD | Yes | No/No | Not listed | No recurrence |
Our case | 2020 | Lt. trisectionectomy | Negative | Gastric | PD | Gastric | LHD | CBD | Yes | Yes/Yes | Yes | 19 |